Automated Stem Cell Transduction via Centrifugal Concentration

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for generating cellular therapeutic agents and genetic modification of stem cells are inefficient and labor-intensive, with low viral transduction efficiency and limited processing capacity, particularly for small cell samples, requiring improved automation and concentration techniques.

Innovation Solution

A process involving a centrifugation chamber with controlled rotational speeds to concentrate stem cells and viral vectors, enhancing transduction efficiency by adjusting volumetric and spatial concentrations, suitable for both large and small cell samples, and performed in a closed, automated system.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If manual or semi-automated procedures are used for cellular therapy and genetic manipulation, then flexibility in handling different cell samples is maintained, but productivity and manufacturing precision are reduced

Engineering Contradiction:
Improveproduction efficiencyVSAvoidautomation system complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The system automatically adjusts critical parameters including rotational speed of the centrifugation chamber, timing of transduction cycles, and concentration of viral vectors based on the specific cell sample characteristics, eliminating the need for manual optimization while maintaining high productivity

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

Manual mechanical operations such as centrifugation, cell harvesting, and reagent addition are replaced by an automated robotic system with programmable control, significantly increasing productivity while managing device complexity through integration

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Quantity of substance

If large volumes of blood products are processed to obtain sufficient stem cells, then adequate cell numbers for therapy are achieved, but processing time and loss of substance increase

Engineering Contradiction:
Improvestem cell yieldVSAvoidcell loss during processing
Core Design Contradiction:
Quantity of substanceVSLoss of substance

Solution Approach 1:

The system performs preliminary concentration of stem cells from large blood volumes before transduction, using controlled centrifugation to pellet cells and reduce supernatant volume, thereby minimizing cell loss and preparing optimized cell suspensions for subsequent genetic modification

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The automated system replicates optimal manual processing techniques with precise control over centrifugation parameters and transduction conditions, achieving high cell recovery rates while maintaining the benefits of automation

Inventive Principle:
Principle #26Copying

3Reliability

If stem cells are cultivated at low concentration in large volumes, then adequate cell numbers are obtained, but transduction efficiency with viral vectors is reduced

Engineering Contradiction:
Improvetransduction efficiencyVSAvoidcell concentration
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The system employs periodic transduction cycles with controlled intervals, where cells are exposed to viral vectors at optimized concentrations for specific time periods, then harvested and re-suspended, repeating the process to achieve high transduction efficiency while maintaining adequate cell numbers

Inventive Principle:
Principle #19Periodic action

Solution Approach 2:

The rotational speed of the centrifugation chamber is dynamically adjusted during transduction to control cell concentration and spatial distribution, creating optimal conditions for viral transduction by concentrating cells and vectors in close proximity

Inventive Principle:
Principle #35Parameter changes

4Reliability

If centrifugation is used to concentrate stem cells for transduction, then transduction efficiency is improved, but cell damage and loss of substance may occur

Engineering Contradiction:
Improvetransduction efficiencyVSAvoidcell damage during centrifugation
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The centrifugation process uses dynamic, variable rotational speeds rather than constant high-speed centrifugation, adjusting the g-force to be sufficient for cell concentration but low enough to prevent mechanical damage to stem cells and their membranes

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The system incorporates gentle resuspension protocols and protective media formulations before and during centrifugation to cushion cells against mechanical stress, preventing damage while achieving the necessary concentration for efficient transduction

Inventive Principle:
Principle #11Beforehand cushioning (Prior cushioning)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This process significantly increases the yield of genetically modified stem cells, improving transduction efficiency and enabling standardized, automated production of cellular therapeutic agents, particularly for rare stem cells, by optimizing cell and vector concentrations within the centrifugation chamber.

Implementation Method 1

a centrifugation chamber with controlled rotational speeds to concentrate stem cells and viral vectors

Methodology Applied
Scientific EffectCentrifugal force: Centrifugal Force

Data Source

PatentEP2937100B1Automated generation of genetically modified stem cells
Publication Date: 2018.06.20 MILTENYI BIOTEC GMBH
  • EP2937100B1 patent drawingFigure 1a~1b
  • EP2937100B1 patent drawingFigure 2
  • EP2937100B1 patent drawingFigure 3

AI summary

The invention relates to a process for generation of genetically modified stem cells comprising the steps a) providing a cell sample in suspension comprising stem cells in a centrifugation chamber comprising a base plate and cover plate connected by a cylinder b) adjusting the volumetric concentration of stem cells in the cell sample to at least 1x105 stem cells per mL cell sample by centrifugation c) introducing viral and/or non-viral vectors to the centrifugation chamber for genetically modifying the stem cells d) adjusting the spatial concentration of stem cells in the centrifugation chamber by rotating the centrifugation chamber at a speed where the cell sample is located at the outermost 35% of the radius of the base plate of the centrifugation chamber, thereby inducing gene modification of the stem cells.